Mechanism of membrane interaction and disruption by α-synuclein by Reynolds, Nicholas P et al.
The mechanism of membrane interaction  
and disruption by α-Synuclein 
Nicholas P. Reynolds1‡, Alice Soragni2‡, Michael Rabe1, Dorinel Verdes1, Ennio Liverani2, Stephan 
Handschin3, Roland Riek2* and Stefan Seeger1* 
 
 
 
1University of Zurich, Institute of Physical Chemistry, Winterthurerstrasse 190, 8057 Zurich, 
Switzerland, *sseeger@pci.uzh.ch.  
2ETH Zurich, Institute of Physical Chemistry, Wolfgang-Pauli Strasse 10, 8093 Zurich, Switzerland, 
*roland.riek@phys.chem.ethz.ch 
3Electron Microscopy Center ETH Zurich (EMEZ), Schafmattstrasse 18, 8093 Zurich, Switzerland,  
 
‡These authors contributed equally to the work. 
 
 
 
 
 Abstract  
Parkinson`s disease is a common progressive neurodegenerative condition, characterized by the 
deposition of amyloid fibrils as Lewy bodies in the substantia nigra of affected individuals. These 
insoluble aggregates predominantly consist of the protein α-Synuclein. There is increasing evidence 
suggesting that the aggregation of α−Synuclein is influenced by lipid membranes and, vice versa, the 
membrane integrity is severely affected by the presence of bound aggregates. Here, using the surface 
sensitive imaging technique super critical angle fluorescence microscopy and Förster resonance energy 
transfer we report the direct observation of α−Synuclein aggregation on supported lipid bilayers. Both 
the wild-type and the two mutant forms of α−Synuclein studied, namely the familiar variant A53T and 
the designed highly toxic variant E57K, were found to follow the same mechanism of polymerization 
and membrane damage. This mechanism involved the extraction of lipids from the bilayer and their 
clustering around growing α−Synuclein aggregates. Despite all three isoforms following the same 
pathway, the extent of aggregation and their effect on the bilayers was seen to be variant and 
concentration dependent. Both A53T and E57K formed cross β-sheet aggregates and damaged the 
membrane at sub-micromolar concentrations. The wild-type also formed aggregates in this range; 
however, the extent of membrane disruption was greatly reduced. The process of membrane damage 
could resemble the yet poorly understood cellular toxicity phenomenon in vivo.   
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 Introduction 
   α−Synuclein (α−Syn) is a small, highly conserved protein composed of 140 amino-acid residues 
expressed predominantly in pre-synaptic terminals in the brain.1,2 The physiological function of α−Syn 
remains debatable, but it is thought to play a role in the maintenance of the synaptic vesicle reserve pool 
of the brain,3,4 and to possess chaperone-like activity for the assembly of SNARE complexes.5  
α−Syn is remarkable for its structural variety; in aqueous solutions monomeric α−Syn is reported to 
be a natively unfolded polypeptide chain, although a recent report from Bartels and co-workers suggest 
that the physiological conformation is an α-helical folded tetramer.6 Upon interaction with membrane 
mimetic detergent micelles it is folded into a structure containing two antiparallel α-helical regions.7 
Structural studies of α−Syn adsorbed to more physiologically relevant small negatively charged 
unilamellar vesicles (ULVs) have revealed either similar antiparallel helical structures,8 or alternatively 
one extended helix.9,10 α−Syn can also self aggregate into amyloid fibrils,11 rich in cross β-sheet 
structure. Such large fibrillar aggregates are the major component of Lewy bodies (LBs) found in the 
intracellular space of neurons and glia cells in the substantia nigra of Parkinson`s disease (PD) patients 
as well as LB dementia (LBD) affected individuals.12 
The majority of cases of PD are of the late onset idiopathic type, of unknown etiology. In addition, 
there are much rarer inherited autosomal dominant cases, which are associated with a gene 
multiplication of the wild-type (WT) or point mutations in the α−Syn gene.13-16 The first mutant 
identified was the A53T variant, found in families of Greek and Italian origin.15 Although in both the 
idiopathic and familiar PD cases the deposition of the high molecular weight α−Syn aggregates in the 
neuronal tissue is a ubiquitous pathological feature, there is a growing body of evidence that LBs 
represent a non-toxic end state and are not directly responsible for the symptoms of the disease.17-19 
However, a recent study indicates that neurons bearing LBs have a shorter life span20 therefore the 
influence of the presence of LBs remains unclear. Nevertheless, the presently most accepted hypothesis 
is that soluble or partially soluble oligomeric pre-fibrillar intermediates arising from the process of 
 aggregation of α−Syn may be the toxic culprits. Insights into the mechanism of toxicity was provided 
by observing the tight membrane binding21 and permeabilization of ULVs by α−Syn.22 This effect was 
more dramatic for mutant forms of α−Syn, compared to the WT.22 Hypothesized mechanisms of 
permeabilization include membrane adsorption of α−Syn aggregation intermediates, followed by 
penetration of the cell membrane forming pores in the bilayer.22-24 Alternatively lipid bound helical 
α−Syn can cause tubulation of negatively charged vesicular25 and supported bilayers.26 This is thought 
to be related to the suggested physiological vesicle trafficking role of α−Syn, however excessive 
tubulation has been shown to cause membrane disruption.25 In addition, membrane thinning was 
proposed as a possible toxic mechanism for other amyloidogenic proteins including Aβ.27 
Conventionally, interactions between aggregates of α−Syn and lipids are studied by following the 
adsorption of protein to ULVs in solution and observing the effects by spatially averaging spectroscopic 
or fluorescent techniques.22,28Although this approach has provided valuable knowledge of the 
interactions of α−Syn with lipids, it does not allow the direct visualization of protein aggregates on the 
membrane. Supported lipid bilayers (SLBs) are planar fluid membranes formed by the fusion of ULVs 
onto hydrophilic surfaces. They offer an attractive model for the study of protein aggregation on 
membranes due to their simplicity compared to cell membranes and their ease of formation on solid 
supports, making them ideal for use with surface sensitive imaging techniques. Furthermore labeling 
with donor and acceptor fluorophores allows inter-protein,29 intra-protein30 and also protein-lipid 
interactions31 to be studied by Förster resonance energy transfer (FRET). Traditional microscopy 
techniques cannot easily distinguish between fluorescence from surface-bound molecules and 
background signal from fluorophores in the solution. In the work presented here, this disadvantage was 
overcome using super critical angle fluorescence (SAF) microscopy, which excludes all fluorescence 
except that arising from within ~ 200 nm of the surface.32,33 Thus the adsorption of α−Syn can be 
studied in real time with no need for washing steps to remove unbound protein from the bulk solution. 
This approach has previously proven useful in showing time resolved surface bound processes for a 
 variety of biomolecules.29,34,35 Additional to the surface sensitive imaging, the SAF microscope can 
simultaneously collect under critical angle fluorescence (UAF). The images from the UAF channel 
correspond to those captured from a traditional laser scanning confocal microscope. As with traditional 
optics the collection efficiency of the UAF channel extends 2 to 3 µm into the bulk solution.33   
Here, SAF was used together with a combined immuno/dye stain approach to study the behavior of 
three different variants of α−Syn on the surface of negatively charged SLBs, including the human WT 
α−Syn, the familial variant A53T which displays accelerated kinetics of fibrils and oligomers formation 
in vitro17,36 and also increased toxicity in some animal models37 and the designed E57K variant. E57K 
was shown to be more cytotoxic in a rat model of PD compared to the WT and appears to form more 
membrane-bound oligomers in vivo than the WT and all familial variants.38 
Experimental Section 
Lipid Labeling 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) in chloroform was used as received (Avanti 
Polar Lipids). Dy647-N-hydroxisuccinimide (NHS) ester dye molecules (Dyomics) were used as 
fluorescent labels. The DOPE-Dy647 (donor label) complex was formed by the addition of DOPE (7 
mg) in chloroform to Dy647-NHS (0.2 mg) in methanol together with 0.05 % triethylene amine (TEA) 
(Sigma Aldrich). The resulting mixture was stirred at room temperature for 48 hours. The crude reaction 
product was dried and re-suspended in a 1:2:1 mixture of water: chloroform: methanol, and the organic 
phase containing pure donor labeled DOPE lipids was extracted. The purity of the labeled lipids was 
checked by HPLC. The final labeled lipids were stored in chloroform (10 mg ml-1) at -20 oC.  
Protein Expression and Purification 
The wild-type α−Syn containing plasmid was a gift of Dr. Goedert (MRC Cambridge). The plasmid was 
modified mutating the codon 136 from TAC to TAT in order to avoid cysteine misincorporation at that 
position.39 All the mutant plasmids used in the study were generated by site-directed mutagenesis 
 (QuickChangeII, Stratagene) and verified by sequencing. 
The protocol followed for protein expression and purification of wild-type and variant α−Syn was 
adapted from a previous paper, with minor modifications discussed in detail in the supporting 
information.40 Further purification steps of α-Syn were performed as follows: the lyophilized protein 
was resuspended in cold PBS at a concentration of 2 mg/ml and dyalized against the same buffer at 4° C 
using 3.5 kDa membranes (Slide-A-Lyzer, Pierce). The clear solution was then filtered through a 100 
kDa spin filter (Amicon Ultra, Milipore) to remove potential low molecular weight aggregates. It should 
be noted that small changes to the purification protocol have been shown to result in large variability in 
aggregation propensity.38 The protein concentration was adjusted at 1 to 1.5 mg/ml with PBS at pH 7.4 
and kept frozen until needed.  
Forming Supported Lipid Bilayers 
1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS), 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) in chloroform (Avanti Polar Lipids) were used as supplied. DOPC, DOPS and donor labeled 
DOPE lipids were combined in appropriate ratios. It was determined that a 1 : 2500 ratio of DOPE-
Dy647 : (65 % DOPC / 35 % DOPS) gave an optimum fluorescence intensity in the SAF microscope. 
The low concentration of fluorophores present in the bilayers is a consequence of the high sensitivity of 
single photon counting avalanche photo diodes used as detectors in the SAF microscope. The DOPS 
lipids were added in order to provide the necessary net negative charge on the bilayer to promote α−Syn 
 binding.41 The mixture was stirred under reduced pressure in order to remove the solvent. The resulting 
solid was placed under high vacuum (10 mbar) overnight to remove any traces of chloroform. The dried 
lipids were resuspended in membrane buffer (NaCl (100 mM), CaCl2.H2O (3 mM), Tris (10 mM), pH 
7.5) (Sigma Aldrich) and extruded over 40 times through a porous membrane (0.1 µm pore size) in 
order to produce ULV with a homogenous size distribution. 
 Solutions of ULV (0.1 mg ml-1) in membrane buffer were passed through a flow cell (V = 0.2 ml) over a 
piranha cleaned (piranha solution composes of 1 part 35 % hydrogen peroxide and 3 parts conc. sulfuric 
acid), hydrophilic glass slide. Upon reaching a critical concentration, adsorbed ULVs fuse to form intact 
SLBs.  
Protein Labeling  
Cy7-monofunctional NHS ester dye molecules (Amersham) were used as fluorescent labels (acceptor 
label). Dye to protein coupling was achieved by the addition of 0.2 mg of lyophilized Cy7-NHS to 1 ml 
of protein solution (~ 2 mgml-1) in PBS buffer at pH between 8 and 9. The mixture was shaken at room 
temperature for 16 to 60 hours with very similar results in terms of labeling ratios. UV/Vis spectroscopy 
was used to determine dye to protein ratios using the following extinction coefficients:  λmax(Cy7)/ 747 
nm (ε/ dm3 mol-1 cm-1 250 000), λmax (α-Syn)/  280 nm (ε/ dm3 mol-1 cm-1 5960) ratios between 0.4 and 
0.6 were achieved for all proteins. Despite these low labeling ratios FRET from the fluorescent SLB was 
still visible in the recorded images. Unreacted dye molecules were separated from labeled proteins via 
size exclusion chromatography using a SuperdexTM 200 10/300 GL column (Amersham). After labeling 
all monomeric protein solutions were stored at concentrations below 50 µM at 4o C in the dark. 
SAF Microscopy  
Images of donor labeled fluorescent bilayers and acceptor labeled α−Syn were recorded with a custom 
made microscope based on SAF detection. The technique uses a parabolic shaped lens in order to 
exploit the selective and highly sensitive detection of fluorophores near the dielectric interface, whereas 
the fluorescence from the bulk solution is collected through a separate optical path allowing for 
simultaneous collection of surface sensitive (SAF) and bulk (UAF) fluorescence. See Verdes et al.33 for 
a detailed description of the optical set-up. Scans are formed by moving a scanning table of a maximum 
area of 75 x 75 µm. All measurements were conducted by passing buffered solutions of protein at the 
desired concentration over the fluorescent SLB through the flow cell with a volume of 200 µl at a 
 constant pump rate of 0.25 ml min-1. The collection of FRET in the SAF channel was made possible by 
splitting the fluorescence emission into donor and acceptor signals via a dichroic mirror at 730 nm. 
Donor and acceptor signals were corrected for background emission and for the crosstalk between the 
two channels.42 Protein to lipid ratios (p:l) were calculated by estimating the number of lipids occupying 
the surface area of 6500 mm2 (which is the surface area of the SLB in the flow cell) and assuming that 
each lipid head group occupies an area of 0.5 nm2 and dividing this number by the number of α-syn 
molecules the volume of the flow cell (flow cell p:l, volume ~ 200 µl)  or the total amount of protein 
passing through the flow cell in one experiment (total p:l, volume ~ 5 ml). The flow cell p:l varied from 
1:4050 (200 nM) to 1:270 (3 µM), and the total p:l varied from 1:21.6 (200 nM) to 1:1.44 (3 µM), 
respectively.   
Fluorescence Microscopy  
For standard confocal microscopy, the coverslips were removed from the flow cell and applied to a 
LabTek II borosilicate chamber (Nunc). The samples were kept in PBS buffer, and the p-FTAA dye (1 
mg/ml) was filtered through a 0.22 µm filter and added directly to the solution at either 1:500 or 1:1000 
dilutions. Images were acquired with an inverted Leica DM IRE2 and processed with the Imaris 
software. To record the emission spectra, series of scans were acquired between 420-650 nm with a 10 
nm slit when exciting at 405 nm, or between 495-700 nm when exciting at 488 nm. Intensities of the 
selected spots were obtained using the Leica LCS software. 
Immunofluorescence 
For the antibody study, A11 (Invitrogen) and OC (courtesy of Prof. Glabe, University of California, 
Irvine) antibodies, both raised in rabbit, were directly labeled using the Zenon kit (Invitrogen) according 
to manufacturer’s instruction. The conjugated A11-Alexa-555 and OC-Alexa-488 resulting antibodies, 
were diluted to either 1:250 or 1:500 in 10 % normal goat serum (Sigma Aldrich) in PBS. The SLB with 
or without protein were placed in a 4-well Labtek II Chamber (Nunc) and incubated with the diluted 
 antibodies for 1 hour at room temperature. The samples were then washed twice in PBS and fixed for 15 
minutes with 2 % formaldehyde in PBS. 
CryoSEM 
Glass coverslips of 10x8 mm were precut and extensively washed before being applied to the flow cell. 
For all the experiments, the protein was flushed at a concentration of 400 nM for 24 hours before being 
removed and washed once in ammonium acetate and three times in double distilled water. The 
coverslips were then plunge frozen in liquid ethane and transferred to the freeze-fracturing system EM 
BAF 060 (Leica, Vienna, Austria). Freeze drying was done at -90°C for 60 min before coating the 
sample with 2 nm tungsten at 45° followed by 2 nm at a varying coating angle from 45 to 90°.  Cryo-
SEM was performed in a field emission SEM Leo Gemini 1530 (Carl Zeiss, Oberkochen, Germany) 
equipped with a cold stage to maintain the specimen temperature at -120°C (VCT Cryostage, Leica, 
Vienna, Austria). SE-electrons (acceleration voltage 5 kV) were used for image formation. 
Results 
Surface-Bound α−Syn Affects Bilayer Mobility 
To investigate the interplay between membranes and α-Syn, the composition of the SLBs was chosen 
to include 35 mol % of the anionic phospholipid DOPS to provide a negative charge important for the 
interaction between membrane and α-Syn.21,43 Fluorescence recovery after photobleaching (FRAP) 
measurements were performed on the SLBs before and ~ 24 hours after protein addition for all 3 
variants (Fig. 1), in order to characterize how the adsorption of α−Syn affects the SLBs. Complete 
recovery of the fluorescence in the photo-bleached regions was seen after ~ 30 min for the freshly 
formed SLBs, indicating that the lipids contained within displayed lateral mobility (solid line in Fig. 1). 
However, SLBs showed a significant reduction in mobility upon the adsorption of α−Syn at a 
concentration of 400 nM. All α-Syn variants studied caused between 40 % and 50 % reduction in 
 recovery 30 min after bleaching (Fig. 1 dashed line). These results indicate that upon adsorption to the 
SLBs, α−Syn interacts with the lipids possibly penetrating the surface of the bilayer resulting in a 
reduction of mobility of the lipids within. The result is in agreement with studies using electron spin 
resonance (ESR) and polarized infrared spectroscopy, which showed the adsorption of α−Syn causes a 
reduction in mobility,44 as well as an ordering of lipids in defect regions of ULVs.45 The FRAP 
measurements however do not give insight into the aggregation state of the α−Syn, nor do they resolve 
any effects specific to individual variants. Therefore, fluorescent microscopy was used to visualize the 
membrane adsorption of α−Syn and the formation of surface-bound aggregates. 
Wild-type and Variants of α−Syn Aggregates on SLBs 
In the absence of α−Syn, freshly formed SLBs containing a small fraction of donor labeled lipids 
(0.04%) displayed a uniform fluorescence when imaged by SAF microscopy (Fig. 2, 0 h). Subsequently, 
the donor labeled SLBs were imaged after the addition of 400 nM solution of monomeric acceptor 
labeled α−Syn for 18 to 24 hours. Fig. 2 shows representative images of the same area of the bilayer 
before and at various times after the addition of the three α−Syn variants into the flow cell. For each 
time point the fluorescence arising from the donor fluorophores in the bilayer (left column), from the 
acceptor fluorophores (centre column), and also the FRET efficiencies (right column) is shown. WT 
α−Syn had no visible effect on the SLBs at starting concentrations between 100 and 300 nM 
(Supporting Fig. S1). At 400 nM aggregates were clearly visible on the surface of the SLBs after an 
incubation period of 24 hours.  
In addition to the WT α−Syn, the effect on aggregation of the familial A53T and the E57K variants 
were also studied. For the A53T at a concentration of 400 nM small aggregates appeared in the acceptor 
and FRET channels within two hours of protein addition, indicating a rapid formation of aggregates that 
are closely bound to the SLBs enabling energy transfer to occur. Indeed, the Förster radius of the Cy7-
Dy647 dye pair is 7.13 nm,29  therefore at typical FRET efficiencies of 20 - 30 %, the distances between 
 fluorophores were between 8.5 and 9.3 nm. After 24 hours the size of the adsorbed aggregates, and also 
the FRET efficiency increased significantly. 
An analogous behavior to the A53T variant was observed when 400 nM of E57K was incubated onto 
SLBs (Fig. 2). After 1 to 2 hours of protein adsorption the FRET images revealed the appearance of 
aggregates that continued to grow with the addition of protein, producing large extended structures after 
24 hours (Fig. 2). The cross section shown in Fig. 2 illustrates the growth of one such aggregate over 
time. The increase in fluorescence intensity shows that after their initial formation on the bilayer the 
aggregates continue to grow across its surface. It is worth noting that while the aggregates formed 
within the first two hours grew over time, new aggregates continued to be formed on the surface of 
SLBs although with less frequency. This finding indicates that the affinity of α-Syn was higher to the 
aggregates than to the SLBs (Fig. 2). In contrast to A53T and WT, the E57K variant formed visible 
aggregates on the SLBs at concentrations lower than 400 nM. At concentrations of 200 nM it was 
possible to observe clusters of this variant after 2 hours (Supporting Fig. S1). In summary, at starting 
concentrations of 200 nM only the E57K mutant formed visible aggregates on negatively charged SLBs, 
whereas at 400 nM aggregation occurred for all variants, but was more pronounced for the two variants. 
The concentration of negatively charged lipids is enriched in the inner leaflet of the plasma membrane 
of most cell types, constituting up to 25 mass % of total lipids.46 As α-Syn is a cytosolic protein it can 
interact with this class of phospholipids. The composition of the SLBs used in this study was 35 mol % 
(36 mass %) therefore, in order to strengthen the argument about the physiological relevance of the 
present study we also measured α-Syn aggregation and lipid extraction on the membrane surface with 
SLBs containing 21 mass % DOPS lipids.  Even with the reduced negative charge on the SLB the 
effects documented here are still present although less pronounced (Supporting Fig. S2). 
Surface-Bound α−Syn Aggregates Affect the Bilayer Integrity 
Interestingly, an increase in fluorescence intensity was observed in the donor channel at the points of 
aggregate adsorption. This occurred frequently for both the A53T and E57K variants, but less for the 
 WT (Fig. 2). As donor fluorophores were present only on the lipid molecules, this increased 
fluorescence is attributed to a clustering of negatively charged lipids in the regions of the SLBs where 
α−Syn aggregates were present. In order to confirm that this increase in signal was not an artifact of the 
labeled protein, the experiment was repeated with unlabeled A53T α−Syn. After 24 hours, features 
qualitatively identical to those seen in Fig. 2 were observed, indicating that the presence of the label has 
no influence on lipid clustering (Fig. 3a). However, the possibility still remained that the observed 
clustering was due to an increased affinity of the aggregates to the labeled lipids. To disprove this, the 
experiment was repeated with SLBs containing different amounts of fluorescently labeled lipids ranging 
from 0.004 – 1 %. When using 0.04 % fluorescent lipids or 10 times less fluorophores 0.004 %, (Fig 3a 
and Supporting Fig. S3 respectively), the relative increase in fluorescence intensity arising from dye-
labeled lipids at α-Syn adsorption sites was always 2 – 2.5 times greater than the signal from the 
undamaged SLBs. Similiarly, for SLBs containg 1 % DOPE-Dy647 (Fig. 3b) the relative increase in 
fluorescence intensity at α-Syn adsorption sites was again between 2 – 2.5 times that of the undamaged 
regions of bilayer.  
 In order to determine if fluorescence from the clustered lipids was confined to the surface of the bilayer 
or extended away from the surface, we employed both UAF and SAF channels of the SAF microscope. 
In the SAF channel we saw the expected increase in fluorescence intensity due to clustered lipids. In the 
majority of the cases these features are reproduced in the UAF channel indicating the lipids extend into 
the bulk solution away from the SLB plane (Fig. 3a). Despite the sensitivity of the UAF channel being 
five times lower than that of the SAF,33 the fluorescence from the clustered lipids was more intense in 
this channel. This increase in intensity is due to lipids absent from the SAF detection volume, which 
extend away from the plane of the SLB. To further highlight this observation, several confocal plane 
images at different distances from the SLBs were acquired with a standard confocal microscope. Figure 
3b shows two of these confocal planes, the first of these is focused on the surface of labeled SLB 
imaging aggregates of lipids and protein stained with the Dy647 and the amyloid specific p-FTAA dye 
 respectively. The second plane extended 1.6 µm away from the bilayer and clearly showed fluorescence 
from both aggregates and extracted lipids extending far from the SLB into the solution.  
Incubation of WT α−Syn at a starting concentration of 3 µM for 24 h appeared to cause extensive 
damage to the membrane as seen by the appearance of dark holes in the SLBs (Fig. 4b). Interestingly, 
the same extent of damage was not observed at 1.5 µM (Fig. 4a) for the WT, but was for both the A53T 
and E57K variants (Fig. 4c).  
Structural Characterization of the Protein Aggregates 
The aggregates present on the SLBs after 24 hours of incubation varied in size from a few to tens of 
micrometers (Fig 2 and. 3a). To understand if aggregates from Figures 2 and 3a resembled an end point 
aggregated state, i.e. mature amyloid fibers, donor labeled SLBs were flushed with an unlabeled 400 nM 
protein solution for 24 hours as previously described. After this time, the coverslip was removed from 
the flow cell and transferred into LabTek II borosilicate chambers filled with PBS. Upon addition of the 
dye p-FTAA, able to bind to mature fibrils and to pre-fibrillar species,47,48 the aggregates displayed a 
characteristic fluorescence (Fig. 5 Supporting Fig. S4) with emission spectra exhibiting two maxima 
occurring around 515 and 545 nm typical of amyloid bound p-FTAA.47 Additionally, the spectra 
overlapped well with the emission spectra of α-Syn fibrils grown in solution (Supporting Fig. S5). 
Furthermore, colocalization between the amyloid dye p-FTAA with the donor labeled lipids was 
observed (Fig. 5), corroborating the SAF data. 
To further confirm the amyloid nature of the aggregates, the samples were stained with an Alexa-488 
labeled OC antibody,49 specific to the cross β-sheet amyloid structure regardless of the primary 
sequence of the protein of origin (Fig. 6).49 The OC binding further confirmed that the protein 
aggregates were at least partially composed of mature fibers containing cross β-sheet structure. The 
same experiment was measured by SAF microscopy directly in the flow cell with similar results 
(Supporting Fig. S6). This confirms that manipulation of the coverslips (i.e. removal from flow cells, 
 washing steps) did not qualitatively alter the samples, although such handling did result in a loss of 
SLB-bound aggregates. 
In order to observe the morphology of the adsorbed aggregates with a higher resolution, samples of 
E57K adsorbed on SLBs were imaged by cryo scanning electron microscopy (cryoSEM), representative 
images of which are shown in Figure 6 and S7 for negative control. Typical fibril morphologies were 
observed looking qualitatively identical to fibrils grown under shaking conditions and deposited on 
clean SLBs (Fig. 6). The smaller size of the observed fibrils compared to the SAF data was attributed to 
the loss of large fibrils during the handling of the cover slips.  
To investigate if pre-fibrillar oligomeric intermediates were also present in the α-Syn aggregates 
attached to SLBs, immunostaining using the A11 antibody, specific to pre-fibrillar toxic oligomers,50 
was performed. Indeed, after 24 hours of incubation of the E57K variant a few A11 binding particles 
were occasionally detected (Fig. 6) partially overlapping with the OC-positive spots (Fig. 6).  
In an attempt to quantify the amount of protein adsorbed to the membrane in a β-sheet conformation, 
a circular dichroism (CD) experiment was performed. As previously, the experiment was performed in a 
flow cell and a 3 or 10 µM solution of WT α-Syn, necessary to gain enough signal in the CD, was 
washed over the SLB for 24 hours. Analysis of the bulk solution reveled that the overwhelming majority 
of the protein remained in an unstructured conformation in solution (data not shown). 
Bilayer Integrity is conserved in the Absence of α-Syn Aggregation 
To determine the role that amyloidogenic aggregation taking place on the surface of the SLB plays in 
the process of membrane damage, two additional experiments were performed. First, the experiments in 
Figure 2 were repeated with the addition of an equimolar amount of dopamine, shown to inhibit α-Syn 
aggregation.51,52 Figure 7a illustrates the effect of this experiment when 400 nM of acceptor labeled 
E57K α-Syn was incubated on a donor labeled SLB in the presence of dopamine. Some clustering of 
lipids was observed in the donor channel, although much less pronounced than in the absence of 
dopamine (Fig 2). In addition there was no evidence of lipid extraction in the UAF channel. Generally 
 the clustering of lipids was accompanied by a marked increase in the fluorescence in the acceptor 
channel, due to energy transfer from the fluorescently labeled lipids to the aggregating protein (Fig 2). 
This was not observed in the presence of dopamine (Fig 7a). To exclude the possibility that dopamine 
prevented the adsorption of α-Syn to the SLB, and therefore the lipid clustering was caused by the 
dopamine itself, we performed the same experiment in the absence of α-Syn. Dopamine had no effect 
on the integrity of the SLB after 20 h, and no lipid clustering was observed (Fig 7b). Moreover the 
mobility of the lipids within the SLB was reduced in the presence of α-Syn plus dopamine, but not 
affected in the presence of dopamine alone (Fig. 7c) suggesting that α-Syn is still adsorbed to the 
bilayer.  
α-Syn fibers show no effect on donor labeled SLBs 
To determine the role that amyloidogenic aggregation taking place on the surface of the SLB, plays in 
the process of membrane damage, it was tested whether the addition of pre-formed α-Syn fibers had any 
effect on donor labeled SLBs. The addition of 3 µM E57K pre-formed fibers caused no major 
perturbation of the membrane as observed in the SAF channel (Fig. 7b), although a small amount of 
lipids were clustered by the bound fibrils (Fig. 7b UAF channel).  This observation indicates that the 
process of aggregation rather than the presence of mature amyloid fibrils is important for membrane 
damage.  
Discussion 
An aggregated state of the protein α-Syn is believed to cause PD, a neurodegenerative condition 
characterized by the death of dopaminergic neurons in the substantia nigra53 and the presence of 
intracellular α-Syn fibrillar aggregates (LBs).12 Despite the increasing number of animal models 
recapitulating one or more features of the disease, and extensive in vitro studies mimicking aggregation, 
the nature of the toxic α-Syn entity is still under debate. While some studies have found a direct positive 
correlation between α-Syn, fibrillar LBs and cell death,20 others indicated that fibril formation may not 
 directly induce neurodegeneration.18 Thus, it was suggested that oligomeric intermediates of α-Syn 
generated in the process of amyloidogenic aggregation could be the species responsible for cell 
death.19,38,54,55 In addition, the mechanism of toxicity is also unknown. It has been proposed, that α-Syn 
oligomers may penetrate the cell membrane generating voltage-gated channels.24 Alternatively, the loss 
of α-Syn function due to aggregation may cause PD.5,56 Finally, a recent study showed that in vitro the 
aggregation of α-Syn into amyloid fibrils is driven by physiologically irrelevant air-water interfaces57 
thus questioning the validity of the current knowledge on α-Syn nucleation and aggregation. In short, 
neither the process of α-Syn aggregation, the toxic entity of α-Syn, nor the mechanism of toxicity 
causing PD is known. 
α-Syn Aggregates on Membranes 
Towards unravelling some of the questions stated above, the presented study measured the interplay 
between α-Syn and negatively charged SLBs close to physiological conditions.  While the interaction of 
α-Syn with the membrane initially induces an α-helical rich structure,7 here it was observed that in the 
absence of cellular partners α-Syn self-aggregates on the bilayer at sub-physiological concentrations 
(Fig. 2). The majority of the protein however remains unbound from the bilayer in solution as a random 
coil, as shown by CD.  The surface bound aggregates that are present grow to form micrometer size 
amyloid-like entities, proven by the positive p-FTAA stain  (Fig. 3 and 5), the OC antibody binding and 
the cryoSEM images (Fig. 6). Since the established in vitro aggregation process is apparently based on 
physiologically non-relevant air-water interfaces,57 it appears that the fast amyloid aggregate formation 
seen here, presents an alternative aggregation pathway of α-Syn including nucleation and aggregation in 
physiologically relevant conditions.  
A Possible Mechanism of Toxicity 
  When α-Syn begins to aggregate on the SLBs, the growing entities capture lipids from the membrane 
resulting eventually (i.e. at higher protein concentration) in membrane disruption. The clustering of the 
negatively charged lipids at the points of α-Syn aggregation is likely due to a mechanism by which 
 membranous material is extracted from the bilayer by the growing aggregates and transferred to the 
surface of the growing particles (Fig. 8).  
 The proposed mechanism suggests the extracted lipids seen at lower concentrations may be pre-cursors 
to more extensive membrane damage resulting in a loss of membrane integrity, and/or the formation of 
pores in the cell membrane leading to uncontrolled diffusion of molecules in and out of the cell. Indeed, 
at higher α-Syn concentration, membrane disruption was observed (Fig. 4) However, the membrane 
thinning, transient alterations of its structure and lateral diffusion properties alone may be sufficient to 
trigger a cascade of events leading to cell death.22,23,27,28  
In comparison to WT α-Syn, the concentration-dependent process of aggregation and membrane 
disruption is most pronounced for the highly toxic variant E57K followed by the familial variant A53T. 
Since A53T α−Syn was shown to be more toxic than WT in mice models37 and the designed variant 
E57K caused considerably higher toxicity in a rat model of PD than WT and all the familial mutants,38 
there is a qualitative correlation between in vivo toxicity and bilayer damage caused by α−Syn 
aggregation presented here. This indicates that the presented measurements offer a simple yet complete 
mechanism by which the adsorption of α−Syn aggregates may lead to membrane damage sufficient to 
trigger toxicity and cell death (Fig. 8).  
The finding that LBs extracted from patients post-mortem contained high concentrations of lipids58 
and the presence of lipid-bound oligomers of α-Syn in the brain of normal or α-Syn transgenic mice as 
well as of PD or LBD patients59 support the proposed mechanism of α-Syn toxicity to be a major 
contributing factor to PD pathogenesis. Moreover, it is interesting to note that a similar mechanism of 
lipid extraction and damage of a bilayer has been observed previously in studies of the aggregation of 
the diabetes type 2-associated islet amyloid polypeptide (IAPP) on SLBs.60 
In our model the extraction of lipids from the surface of the bilayer is due to the amyloidogenic 
aggregation of α-Syn. Support for this hypothesis arises from the observation that the inhibition of α-
Syn aggregation by co-incubation with dopamine prevents lipid extraction and membrane damage (Fig. 
 7b), although FRAP experiments show that the protein still interacts with the SLB (Fig. 7c). Dopamine 
has previously been shown to inhibit α-Syn fibrillation when used at equimolar ratios.51 This is thought 
to occur through hydrophobic interactions with the C-terminus of the protein preventing the formation 
of mature α-Syn fibrils. However, it was shown that co-incubation of α-Syn with dopamine may give 
rise to small pre-fibrillar oligomers.52 The absence of visible protein aggregates in Figure 7a indicates 
that, in the presence of dopamine either oligomers are not formed on the SLB or they do not interact 
with the lipids. 
A Possible Origin of Toxicity 
As mentioned above, it is still debated which conformational species of α-Syn is primarily 
responsible for its toxicity. From the above findings, an alternative viewpoint is proposed; instead of 
one conformation being responsible for toxicity it could be that the origin of toxicity is the mechanism 
itself. Once aggregation is initiated, the repetitive structure of the aggregate (i.e. being a repetitive 
oligomer with a micelle-like structure or an amyloid having the cross β-sheet motif)61,62 continuously 
extracts lipids by aggregate growth.  Since this is an intertwined process, the amyloid may be toxic 
throughout the aggregation process due to repeated cycles of growth and lipid extraction. In contrast, the 
artificial addition of a fibril to a membrane (or a cell) does not result in severe membrane damage (Fig. 
7b), as it binds to the surface of the membrane and only extracts a small amount of lipids. A similar 
scenario may be envisioned for oligomers. When pre-formed oligomers are added to a membrane or a 
cell, they may bind to the membrane and either intercalate or extract small amounts of lipids. Such an 
experiment may result in toxicity,23 however it would only partly resemble the toxic mechanism 
proposed above. In particular, because of the lack of aggregate growth, the extraction of lipids would be 
limited and the mechanism of aggregation starting from α-Syn monomers adsorbed on the membrane 
would be missed entirely. Following this argumentation together with the finding that other 
amyloidogenic proteins were found to aggregate in the presence of lipids60 it is likely that also other 
amyloids associated with diseases may bear in part such a mechanism of toxicity. Indeed, for systemic 
 amyloidosis it has already been proposed that the process of aggregation itself might cause tissue 
damage, since the removal of the amyloidogenic immunoglobulin light chain abolishes toxicity and 
causes functional improvement of the affected organs.63 Similarly, the continuing production of PrPC is 
also required for prion toxicity indicating that also for prion diseases the process of aggregation itself 
may be the origin of toxicity.64 
 
Conclusion 
In the presented study the process of aggregation of WT and two mutant forms of α-Syn on partially 
negatively charged SLBs was investigated. All three proteins, WT, the familiar mutant A53T and the 
artificial mutant E57K aggregated when applied on the surface at nanomolar concentrations. 
Throughout the aggregation process lipids molecules were extracted from the bilayer by the growing 
protein aggregates resulting in membrane thinning. At µM concentration of α-Syn this process resulted 
in extensive bilayer disruption. Both the extent of aggregation and the severity of damage to the 
membrane integrity were correlated with the protein variant applied, with E57K being the most 
aggressive followed by A53T and WT. We hypothesize that the interplay between growth of the 
aggregates and lipids extraction reported here could be relevant to the mechanism of toxicity of α-Syn 
in case of PD. 
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Figure 1: Lipid mobility is decreased by the presence of α-Syn measured by FRAP. FRAP from donor 
labeled SLB before (solid line) and 24 h after adsorption and incubation of 400 nM α-Syn (dashed line). 
Photobleaching at time 0’ was achieved using a pulsed laser (635 nm) at an intensity of 1.6 mW for 10 
min. 
  
Figure 2: SAF images at different incubation times (0, 2, and 24 h) showing adsorption of 3 variants of 
acceptor labeled α−Syn onto donor labeled SLBs. For each variant the left column shows fluorescence 
from the donor channel 0 – 200 (red to yellow) arbitrary units (au), the centre column fluorescence from 
the acceptor channel 0 – 50 au (black to red), and the right column shows FRET intensities 0 – 30% 
(blue to red). The fourth panel shows the evolution of the growth of one aggregate at 1 h (black line), 2 
h (pink), 4 h (green), 8 h (blue), and 24 h (red) after injection of α-Syn E57K.  
 
  
 
Figure 3: Fluorescent microscopy images showing lipid extraction away from the plane of the SLB. a) 
Addition of unlabeled A53T α-syn (400 nM) to a fluorescent SLB, as most of the aggregates show more 
intense fluorescence in the UAF channel (top arrows) indicating lipid extraction from the SAF detection 
volume, bottom arrows shows an area of clustered lipids that is only present in the SAF channel 
therefore confined to the surface of the SLB. b) Confocal images corresponding to different z-planes of 
a z-stack. The p-FTAA stained E57K aggregates formed on the SLB at a starting protein concentration 
of 3 µM (left column) are surrounded by lipids  (middle column, lipids labeled with Dy647). The closest 
plane to the bilayer is indicated as z = 0 µm.  
 
  
Figure 4: SAF images showing membrane damage to donor labeled SLBs by WT and E57K α-Syn. (a) 
and (b) show SLBs 24 hours after WT protein incubation of 1.5 µM and 3 µM respectively, (c) shows 
SLBs 24 hours after incubation of a 1.5 µM solution of E57K α−Syn. All images 0 – 200 au (black to 
yellow). 
 
Figure 5: Characterization by confocal microscopy of α-Syn aggregates formed on SLBs. Donor 
labeled SLBs were incubated for 24 hours with the indicated α-Syn variants before addition of the p-
FTAA dye. Emission spectra of fluorescent areas were acquired to confirm the presence of cross 
β−sheet rich entities. For WT α-Syn the excitation wavelength was 405 nm, for α-Syn E57K - 400 nM 
it was 488 nm. The emission spectra were taken from areas highlighted by the yellow boxes. Scale bars: 
10 µm. 
 
  
Figure 6: α-Syn E57K aggregates formed on SLBs imaged by (a) immunofluorescence and (b) 
CryoSEM. (a) Confocal image of OC and A11 antibody bound to adsorbed α-Syn E57K on donor 
labeled SLBs. The protein clusters formed after 24 hours of incubation were stained with the anti-
amyloid antibody OC, specific to mature amyloid structures. The same particles were partially 
recognized by A11, an antibody specific to oligomeric amyloid precursors. SLBs without adsorbed 
protein were incubated with the same antibodies as a control Scale bars: 2 µm for the E57K sample and 
20 µm for the control. (b) CryoSEM images of aggregates formed on SLBs after 24 hours of incubation 
with 400 nM E57K α-Syn solution as indicated. The left panel shows a bilayer briefly incubated with α-
Syn fibrils aggregated in solution. The two panels to the right show two areas of α-Syn E57K 
aggregated on SLB Scale bars: 100 nm. 
  
Figure 7: a) SAF and UAF images showing the adsorption of acceptor labeled 400 nM E57K α-Syn 
onto donor labeled SLBs in the presence of 400 nM dopamine, b) SAF image of adsorption of dopamine 
alone on donor labeled SLB c) FRAP analysis of the lipid mobility of donor labeled SLBs alone(solid 
line), donor labeled SLB plus 400 nM dopamine after 20 h (large dashes), and donor labeled SLB plus 
400 nM E57K α-syn and 400 nM dopamine after 20 h (small dashes). d) SAF and UAF images of donor 
labeled SLB before and after addition of 3 µM unlabeled E57K pre-formed fibers. All donor and UAF 
scans shown on a scale of (0-200 au) and all acceptor scans (0-50 au).     
 
  
Figure. 8 Schematic drawing showing the proposed mechanism of membrane damage caused by 
aggregation of α-Syn on SLB. a) Monomeric α-Syn adsorbed to the membrane, b) aggregation of α-Syn 
monomers initiates membrane thinning and lipid extraction around the growing aggregates, c) 24 h 
incubation results in the presence of mature α-Syn fibers. Subsequently membrane integrity is lost. 
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